PhilHealth expands coverage for kidney patients | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

PhilHealth expands coverage for kidney patients

/ 05:12 AM August 05, 2022

The PhilHealth is asking private hospitals that have warned of cutting ties with the state insurer to reconsider, assuring that it will pay its unpaid claims to them. 

PhilHealth

The state-run Philippine Health Insurance Corp. (PhilHealth) expanded its treatment coverage for chronic kidney disease patients to a maximum of 144 hemodialysis sessions – up from an earlier maximum of 90 sessions – until December 31, according to PhilHealth Circular No. 2022-0017 that took effect on Wednesday.

However, it noted that sessions 91 to 144 shall be used only for outpatient dialysis while any unused session would not be carried over to 2023.

Article continues after this advertisement

Those who have already reached more than 90 sessions prior to the issuance of the circular may file their benefit claims with any PhilHealth office or local health insurance, the circular stated.

FEATURED STORIES

Those who will not be able to file claims due to natural calamity or other unforeseen events will be given an extension of up to 120 days, provided that the qualified patient is being treated or living in an area under a state of calamity.

Members and their dependents currently enrolled in the PhilHealth Dialysis Database are eligible for this updated coverage, the Department of Health said. —Kathleen de Villa

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
business
business
sports
lifestyle
globalnation
www
business
www
globalnation
sports
TAGS: dialysis, Philhealth

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.